Myriad Genetics reported $116.9M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Accelerate Diagnostics AXDX:US 802K 380K
Agilent A:US $ 861M 49M
Becton, Dickinson and BDX:US $ 2305M 118M
Bio Rad Laboratories BIO:US $ 403.56M 2.66M
Biocept BIOC:US $ 9.61M 5.66M
Bruker BRKR:US $ 306.3M 35.3M
Danaher DHR:US $ 4705M 238M
Exact Sciences EXAS:US $ 351.87M 2.89M
Fluidigm FLDM:US 12.24M 8M
Hologic HOLX:US $ 946.6M 39.7M
Illumina ILMN:US $ 815M 2M
Johnson & Johnson JNJ:US $ 15828M 1021M
Mettler Toledo International MTD:US 519.58M 87.55M
Myriad Genetics MYGN:US $ 116.9M 1.9M
Nanostring Technologies NSTG:US $ 16.3M 6.11M
Orasure Technologies OSUR:US $ 24.27M 2.86M
Pacific Biosciences Of California PACB:US $ 14.16M 2.61M
Perkinelmer PKI:US $ 679.23M 69.89M
Quest Diagnostics DGX:US $ 968M 97M
Quidel QDEL:US $ 739.96M 250.62M
Repligen RGEN:US $ 124.04M 19.57M
Thermo Fisher Scientific TMO:US $ 5464M 210M
Veracyte VCYT:US $ 44.07M 0.38M
Waters WAT:US $ 404.89M 80.56M